HomeMarket NewsMicro Cap Stocks Why Cardio Diagnostics Holdings Stock Is Racing Higher The Road to Triumph: Cardio...

Why Cardio Diagnostics Holdings Stock Is Racing Higher The Road to Triumph: Cardio Diagnostics Holdings Ascends on CPT PLA Code News

Actionable Trade Ideas

always free

ai generated 8437637 1280

Cardio Diagnostics Holdings Inc. CDIO soars as the company secures a dedicated Current Procedural Terminology (CPT) Proprietary Laboratory Analysis (PLA) from the American Medical Association (AMA) for its AI-powered coronary heart disease (CHD) detection test, PrecisionCHD.

The Breakdown:

The receipt of the CPT PLA code marks a pivotal moment for Cardio Diagnostics as it paves the way for billing, payment, and wider adoption of its genetic-epigenetic diagnostic blood test for CHD. Effective from April 1, 2024, the code propels the company’s commercialization efforts forward.

Commenting on the development, Meesha Dogan, Ph.D., CEO of Cardio Diagnostics, stated, “Cardio Diagnostics is unwavering in its commitment to ensuring widespread accessibility to our solutions. The dedicated CPT PLA code for PrecisionCHD represents a crucial milestone in our commercialization strategy. With PrecisionCHD, we are optimistic about expanding equitable access to CHD diagnostics, improving patient health outcomes, and reducing healthcare costs.”

Related News: Why Bitcoin Miners Hut 8 Corp And Hive Digital Technologies Stocks Are Climbing

CDIO Price Action: As per Benzinga Pro, Cardio Diagnostics shares surge by 39% to $3.46 at the time of publication.

Image: Pete Linforth from Pixabay

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.